Background/Aims: Pheochromocytoma and paraganglioma (PPGL) are catecholamine-producing tumors that can cause blood pressure (BP) elevation and cardiovascular complications. Clinical presentation of these tumors may be changed through widespread use of imaging studies, which enables detection of PPGLs before onset of symptoms. We investigated clinical profiles of patients with surgically resected PPGLs. Methods: From 2005 to 2017, 111 consecutive patients with surgically resected PPGLs in two tertiary hospitals in Korea were studied. Results: Mean age was 52 ± 16 years, 57 patients (51.4%) were male and 54 (48.6%) were hypertensive. Twenty-nine PPGLs (26.1%) were extra-adrenal paragangliomas. Sixteen (14.4%) and seven patients (6.3%) (Group 1, n = 23) were diagnosed during work-up of hypertension and transient cardiomyopathy respectively, and the remainder (Group 2, n = 88) were incidentalomas detected during routine abdominal imaging. Patients in the Group 1 were younger and more frequently symptomatic, and had higher BPs, heart rates and levels of urinary catecholamines than those in the Group 2. Paragangliomas were less frequent and secretion of epinephrine and metanephrine was more predominant in the Group 1 than in Group 2. After the surgical resections, 18.2% of patients still needed antihypertensive medications. Conclusions: Out of 111 patients with surgically resected PPGLs, 88 (79.3%) were diagnosed as incidentalomas. Seven patients presented with transient cardiomyopathy and 16 with hypertension. Tumor location and secretion of catecholamine may vary depending on the presence of symptoms.
INTRODUCTION
Pheochromocytoma and paraganglioma (PPGL) are neuroendocrine tumors from chromaffin cells and usually originated from the medulla of the adrenal gland or extra-adrenal location in which chromaffin cells are located [1, 2] . PPGLs release catecholamines into circu-lation, and these can be related to episodic headache, dizziness and palpitation as results of stimulation of beta-adrenergic receptors. Because alpha-adrenergic stimulation can cause elevation of blood pressure (BP), PPGLs are considered one of causes of secondary hypertension. Moreover, excessive catecholamine release increases heart rate and can provoke transient cardio-myopathy (CMP) associated with catecholamine [3, 4] . However, diagnosis of PPGLs is quite challenging because their clinical manifestations are nonspecific and variable, and they are rare tumors. Since widespread use of computed tomography (CT) scans, especially for the purpose of health screening, has led to increased rate of detection of adrenal tumors without symptoms (incidentalomas), the prevalence of clinical presentations suggesting catecholamine excess might have changed from past studies in patients with PPGLs. Thus, we evaluated the clinical presentations of patients with surgically resected PPGLs.
METHODS

Study population
All consecutive patients with PPGLs which were surgically resected and confirmed by pathologic examination were retrospectively enrolled from January 2005 to December 2017 in two tertiary teaching hospitals in Korea (Chungnam National University Hospital [CNNUH] and Chonbuk National University Hospital [CBNUH] ).
Study measures
The baseline demographic characteristics including age, sex, past history of hypertension and antihypertensive medication, clinical symptoms, levels of urinary and plasma catecholamines, and radiologic findings including CT were investigated with the review of medical records. Excretion of 24-hour urinary catecholamines and levels of plasma catecholamines were measured by a liquid chromatographic method (reference, 24-hour urinary norepinephrine < 80 µg/day, epinephrine < 22 µg/day, vanillyl mandelic acid [VMA] < 8 mg/day, metanephrine < 0.8 mg/day, plasma free metanephrine < 0.50 nmol/L, normetanephrine < 0.90 nmol/L, epinephrine 1 to 20 pg/mL, and norepinephrine 15 to 80 pg/mL) [5] . Catecholamine secretion was considered to be significantly increased if the 24-hour urinary excretion of metanephrine, epinephrine or norepinephrine, or plasma levels of metanephrine or normetanephrine was five times higher than their cut-off values.
Electrocardiographic (ECG) findings were classified into four categories: left ventricular hypertrophy by voltage criteria, significant ST-T abnormalities, nonspecific ST-T changes, and normal ECG. Presence of CMP was defined as echocardiographic evidence of left ventricular dysfunction and regional wall motion abnormalities (RWMA) inconsistent with coronary territories or transient RWMA with no evidence of obstructive coronary lesions. The tumor with the presence of local invasion into surrounding organs and tissues or distant metastases was considered to have malignant potential. This study protocol was approved by Institutional Review Board of each hospital (IRB No. CNNUH, 2016-12-047; CBNUH, 2018-07-002) and written informed consent was waived because the study was retrospective and anonymous clinical data were used for analysis.
Statistical analysis
Data are expressed as mean ± standard deviation for continuous variables and as frequencies (percentages) for the categorical variables. Statistical analysis was performed using SPSS version 22.0 (IBM Inc., Chicago, IL, USA) software. A Mann-Whitney U test and Student's t test were performed for statistical comparison between the numeric data, while a chi-square test was performed for the categorical data. Statistical significance was determined as a p value < 0.05.
RESULTS
Clinical characteristics of overall patients with PPGLs
During the study period, a total of 111 patients with PPGLs were enrolled. Mean age was 52 ± 16 years (range, 14 to 81) and 57 patients (51.4%) were male. Mean systolic and diastolic BPs of overall patients were 133.2 ± 23.3 and 80.4 ± 15.0 mmHg, respectively. Fifty-four patients (48.6%) had a history of hypertension and 48 (45.3%) were taking 1.9 ± 0.8 antihypertensive drugs. Their mean BP at presentation was 137.3 ± 27.7/81.9 ± 16.6 mmHg.
ECG was normal in 78 patients (71.6%). Left ventricular hypertrophy by voltage criteria was noted in 22 patients (20.2%), significant ST-T abnormalities in seven (6.4%) and nonspecific ST-T changes in two (1.8%). Echocardiography was performed in 46 patients (41.8%) due to cardiovascular symptoms such as chest pain or dyspnea (n = 8), abnormal ECG (n = 14) or cardiovascular risk factors (n = 8), and for preoperative screening (n = 16). Mean left ventricular ejection fraction (LVEF) was 58.9% ± 10.0%.
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Eighty-two patients (73.9%) had pheochromocytomas and 29 (26.1%) of PPGLs was extra-adrenal paragangliomas in the head and neck, chest, abdomen, and pelvis (middle ear, carotid body, aorta, retroperitoneum, duodenum, bladder, and scrotum). Twenty PPGLs (18.0%) showed malignant potential and four patients (3.6%) had metastatic lesions. After the surgery, 20 patients (18.2%) still needed 1.6 ± 0.9 antihypertensive medications and their BP was 124.8 ± 15.0/74.4 ± 7.1 mmHg.
Comparison of symptomatic PPGLs versus incidentalomas
In 88 patients (79.3%), PPGLs were incidentally found during routine abdominal imaging. Other reasons of work-up for PPGLs were paroxysmal elevation of BP with clinical suspicion of secondary hypertension in 16 patients (14.4%) and transient CMP in seven patients (6.3%). We divided our study patients into two groups; 23 patients with clinical presentations of BP elevation or CMP were classified into Group 1 (suspected group) and the remainders (87 patients) who were diagnosed incidentally into Group 2 (incidental group). Their clinical characteristics and laboratory findings are listed in Tables 1 and 2.
Patients in the Group 1 were significantly younger than those in the Group 2 (44 ± 16 years old vs. 54 ± 15 years old, p = 0.005). Clinical symptoms related to catecholamine excess such as headache (52.2% vs. 6.8%, p < In terms of location, extra-adrenal paragangliomas were significantly less frequent in the Group 1 than the Group 2 (8.7% vs. 30.7%, p = 0.033) although the size of the tumor, malignant potential, presence of necrosis, and distant metastasis were comparable in the two groups ( Table 2 ). The levels of urinary excretion of metanephrine, epinephrine and VMA were significantly higher and increased secretion of epinephrine was more predominant (85.7% vs. 58.5%, p = 0.023) in Group 1 than in Group 2 ( Table 2) . Patients in Group 1 showed significant ST-T abnormalities on ECG more frequently than those in Group 2 (21.7% vs. 2.3%, p = 0.003).
Clinical profiles of patients with catecholamine CMP
The clinical profiles of patients with CMP are summarized in Table 3 . The main symptom was chest pain. ST change and T-wave abnormalities were commonly found in the ECG examinations. Apical ballooning was found in four patients and inverted Takotsubo pattern (basal ballooning) was demonstrated in three patients in the echocardiographic studies. All patients with CMP recovered within 12 days (range, 3 to 12). One patient had cardiogenic shock and was successfully treated with extracorporeal membrane oxygenation for 12 days and continuous renal replacement therapy for 25 days (Fig. 1) .
The clinical characteristics of patients presenting with CMP (n = 7) and those without CMP (n = 104) are shown in Table 4 . All tumors in patients with CMP were pheochromocytomas and their secretion of epinephrine was significantly increased. Patients with CMP had more frequent symptoms, history of hypertension, and higher diastolic BP than those without CMP, and showed trends of more frequent diabetes and dyslipidemia, poorer LVEF and higher need for antihypertensives after surgery (Table 4 ).
DISCUSSION
In this study, we examined 111 patients with surgically resected PPGLs and demonstrated that the majority (79.3%) of patients were diagnosed incidentally and 23 patients (20.7%) were diagnosed during work-up for other causes; 16 (14.4%) for evaluation of BP elevation and seven (6.3%) for work-up of CMP. In patients presented with hypertension or CMP, adrenal locations, increased secretion of epinephrine, and cardiovascular symptoms were more prominent than in those with incidentaloma. PPGLs are catecholamine-producing tumors originated from chromaffin cells in the adrenal glands or along the extra-adrenal sympathetic ganglia. Typical symptoms associated with the secretion of catecholamine include headache, tachycardia, dizziness, and sweating [6] . In our study, the frequency of symptoms associated with PPGLs and the levels of urinary excretion of catecholamines were significantly higher in the Group 1 than in the Group 2. These findings suggest that their symptoms were associated with the excess of catecholamines.
The reported incidence of hypertension is about 80% to 90% of patients with pheochromocytoma and half of them demonstrate sustained hypertension [7, 8] . However, recent popular use of CT imaging can increase the proportion of asymptomatic patients [9] and about 5% to 6% of adrenal incidentalomas have been reported to be PPGLs [10, 11] . Therefore, hypertension can be absent in a substantial portion of patients with PPGLs [12, 13] . A German study [12] including 201 patients diagnosed with PPGL between 1973 and 2007 showed that only 10% of cases presented the typical triad of symptoms; 29.4% of them were incidentally detected and incidentalomas were increasing in recent years. In our study, PPGLs were clinically suspected as a secondary cause of hypertension in only 14.4% of patients with PPGLs because of paroxysmal elevation of BP. Imaging studies done during routine health screening were the most common route of detection of PPGLs in this study. The incidence of hypertension was 48.6% and comparable in both groups. Out of 54 patients with a medical history of [15, 16] or inverted Takotsubo-type CMP (transient mid-or bas- Values are presented as mean ± SD or number (%). SCM, stress-induced cardiomyopathy; SBP, systolic blood pressure; DBP, diastolic blood pressure; VMA, vanillyl mandelic acid; LVEF, left ventricular ejection fraction.
